WO2025247377 - USE OF SULFOXIMINE COMPOUND FOR TREATING LYMPHOMA
National phase entry is expected:
Publication Number
WO/2025/247377
Publication Date
04.12.2025
International Application No.
PCT/CN2025/098418
International Filing Date
30.05.2025
Title **
[English]
USE OF SULFOXIMINE COMPOUND FOR TREATING LYMPHOMA
[French]
UTILISATION D'UN COMPOSÉ SULFOXIMINE POUR LE TRAITEMENT D'UN LYMPHOME
[Chinese]
亚氨基砜类化合物治疗淋巴瘤的用途
Applicants **
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
Inventors
DING, Dawei
YU, Ding
WANG, Xunqiang
ZHAO, Wei
ZHANG, Xiquan
Priority Data
202410685908.4
30.05.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1573 | |
| EPO | Filing, Examination, Granting | 11565 | |
| Japan | Filing, Examination, Granting | 2016 | |
| South Korea | Filing, Examination, Granting | 1784 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,678
Contact Us
Abstract[English]
The present application pertains to the field of medicinal chemistry and provides use of a sulfoximine compound for treating lymphoma. Specifically, the present application relates to use of a compound of formula (I) or a pharmaceutically acceptable salt thereof in the preparation of a medicament for treating lymphoma.[French]
La présente demande se rapporte au domaine de la chimie médicale et concerne l'utilisation d'un composé sulfoximine pour le traitement d'un lymphome. Plus particulièrement, la présente invention concerne l'utilisation d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci dans la préparation d'un médicament pour le traitement d'un lymphome.[Chinese]
本申请属于医药化学领域，提供了一种亚氨基砜类化合物治疗淋巴瘤的用途。具体而言，本申请涉及式(I)化合物或其药学上可接受的盐在制备用于治疗淋巴瘤的药物中的用途。